Third Biennial Symposium on Biology, Diagnosis and Treatment of Lymphomas

The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 15, 2005

Share article


Conference Dates: Friday, October 14, 2005
Conference Location: Marriott West, West Conshohocken, PA

Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania

Conference Brochure: Download PDF version of conference brochure.

Topics Covered: Non-Hodgkins, Hodgkins, Prognostic Markers, New Targeted Therapies

Conference Objectives: At the completion of this conference, participants should be able to:

  1. Discuss the current classification of lymphomas as well as the controversies in diagnosis and their impact on management;
  2. Gain new insight into pathogenesis of lymphomas;
  3. Appreciate the growing role of understanding the basic mechanisms of the disease in diagnosis and treatment of lymphomas;
  4. Critically assess novel diagnostic and therapeutic approaches to lymphomas

Who Should Attend: Clinical Oncologists, Pathologists, Hematopathologists, Oncology Nurses and other health care professional involved in the treatment of patients with lymphoma

Conference Agenda:

  • Welcome and Introduction: John Glick
  • Classification of lymphomas: Dale Frank
  • Biology of non-Hodgkin’s lymphomas: diagnostic and therapeutic implications: Mariusz A. Wasik
  • Biology of Hodgkin lymphoma: Harald Stein (Free Univ. Berlin) 9:40- 9:55 Questions and Answers
  • Proteomic analysis of aberrant cell signaling in lymphomas: Kojo Elenitoba-Johnson (Univ. of Utah)
  • Prognostic markers in small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL): Adam Bagg
  • siRNA expression profile of SLL/CLL: Carlo Croce (Ohio State)
  • Glucose metabolism by lymphoma cells: diagnostic and therapeutic implications: Rebecca Ellstrom (Univ. of Michigan)
  • Antibody-based therapy of lymphomas: John Leonard (Weill/Cornell)
  • Histone deactehylase inhibitors in treatment of lymphomas: Ellen Kim
  • Targeted therapies for SLL/CLL: John Byrd (Ohio State)
  • Targeted therapies for non SLL/CLL small B-cell lymphomas: Stephen Schuster
  • New therapeutic agents for aggressive B-cell lymphoma: Sunita Nasta
  • Closing remarks: Mariusz Wasik/Stephen Schuster

Registration Information: For more information, or to request a brochure, please contact Mary Graham at 215-662-7328 or grahamm@mail.med.upenn.edu.

Conference Fees: $175.00 physician, $95.00 nurses and other health care professionals, No fee for faculty, staff, fellows & students of the University of Pennsylvania

Online Registration
All fields are required.

First Name:
Last Name:
Email Address:
Academic Degree:
Medical Specialty:
Affiliation:
(Hospital, Office, Company)
Address:

( Affiliation Home)
City:
State   ZIP Code:
Daytime Telephone #:
Fax #:
Registration: $175 - Physicians
   Credit Card
   Check

$95 - Nurses & other health care professionals
   Credit Card
   Check

Free - faculty, staff, fellows & students of the University of Pennsylvania

   

Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:

Mary Graham
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854

Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.